MEFEDRONA

[1] Capriola M. (2013) Synthetic cathinone abuse. Clinical Pharmacology: Advances and Applications. 5:109–115

 

[2] Schifano F., Albanese A., Fergus S., et al. (2011) Mephedrone (4-methylmethcathinone; ‘meowmeow’): chemical, pharmacological and clinical issues. Psychopharmacology. 214:593–602

 

[3] Wood D., Dargan P. (2012) Mephedrone(4-methylmethcathinone): What is new in our understanding of its use and toxicity. Progressin Neuro-Psychopharmacology & Biological Psychiatry. 39:227–233

 

[4] Valente M., Pinho P., Bastos M., Carvalho F., Carvalho M. (2014) Khat and synthetic cathinones: a review. Archives of Toxicology. 88:15–45

 

[5] Johnson L., Jonshon R., Portier R. (2013) Current ‘‘Legal Highs”. The Journal of Emergency Medicine. 44:1108–1115

 

[6] Ribeiro E., Magalhães T. Dinis-Oliveira R. (2012) Mephedrone, the New Designer Drug of Abuse: Pharmacokinetics, Pharmacodynamics and Clinical and Forensic Issues. Acta Médica Portuguesa. 25:111-117

 

[7] Green A., King, M., Shortall S., et al. (2014) The preclinical pharmacology of mephedrone; not just MDMA by another name. British Journal of Pharmacology. 171:2251–2268

 

[8] Iversen L., White M., Treble R. (2014) Designer psychostimulants: Pharmacology and differences. Neuroparmacology xxx: 1-7

 

[9] Gregg R., Rawls S. (2014) Behavioral pharmacology of designer cathinones: A review of the preclinical literature. Life Sciences. 97:27–30

 

[10] Wood D., Davies S. Puchnarewicz M., et al. (2010) Recreational Use of Mephedrone (4-Methylmethcathinone, 4-MMC) with Associated Sympathomimetic Toxicity. Journal of Medical Toxicology. 6:327–330

 

[11] Winder M., Stern B., Hosanagar M. (2013) Are “Bath Salts” the next generation of stimulant abuse? Journal of Substance Abuse Treatment. 44:42–45

 

[12] Angoa-Pérez M., Kane M., Kuhn D., et al. (2013) Mephedrone Does not Damage Dopamine Nerve Endings of the Striatum but Enhances the Neurotoxicity of Methamphetamine, Amphetamine and MDMA. Journal of neurochemistry. 125:102-110

 

[13] Meyer M., Wilhelm J., Peters F., et al. (2010) Beta-ketoamphetamines: studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine using gas chromatography–mass spectrometry. Analytical and Bioanalytical Chemistry. 397:1225–1233